METiS Therapeutics

United States
Primghar, Iowa, United States, 02140

Company profile

METiS Therapeutics company profile

METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
02140
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$176.2M
Last funding
Series B / $75M / 2022-04-05
Last equity funding
Series B / $75M
Investors
11
Lead investors
4
Founders
1
Articles
3

Founders and investors

Founders

Chris Lai

Lead investors

China Life InsuranceHSGPICC Capital Investment ManagementPicc Group

Investors

5Y CapitalFrees FundHSGLuminous Ventures (former Lightspeed China Partners)Monolith Management